Anger Control Training for Youth With Tourette Syndrome

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT00486551
Collaborator
National Institute of Mental Health (NIMH) (NIH), Tourette Association of America (Other)
26
1
53
0.5

Study Details

Study Description

Brief Summary

This is a clinical study of a cognitive-behavioral therapy known as anger control training in adolescents with Tourette Syndrome and explosive, disruptive behavior. ACT is compared to treatment as usual (TAU) in a randomized clinical trial.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Anger control training
N/A

Detailed Description

This is a randomized controlled study of a cognitive-behavioral, anger control training (ACT) in adolescents with Tourette Syndrome (TS) complicated by disruptive behavior. Disruptive behaviors in TS may take numerous forms including noncompliance, anger outbursts, and physical aggression. Anger outbursts in TS have been described as rage attacks or rage storms due to their high intensity and unpredictability in response to minimal provocation. Whether these behaviors are part of TS, related to comorbid conditions, or due to the burden of chronic illness is not clear. Nevertheless, these disruptive behaviors can result in significant functional impairment and often require clinical attention. The purpose of the ACT intervention is to improve the explosive and noncompliant behavior in adolescents with TS by enhancing affect regulation and social problem-solving skills. The treatment is based on anger control training which has been empirically supported for reducing aggressive behaviors and improving social functioning in aggressive youths. The primary outcome measures include the parent-rated Oppositional Defiant Scale and the Clinicians Global Improvement Score assessed by a clinician blind to treatment assignment.

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
Anger Control Training for Youth With Tourette Syndrome
Study Start Date :
Aug 1, 2001
Actual Study Completion Date :
Jan 1, 2006

Outcome Measures

Primary Outcome Measures

  1. CGI-I assigned by clinician unaware of treatment assignment [three months]

  2. Parent rated disruptive behavior [three months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Boys and girls, 11 to 16 years of age.

  2. Diagnosis of Tourette syndrome (TS) or chronic tic disorder (CTD).

  3. Significant level of disruptive behavior

Exclusion Criteria:
  1. Current diagnosis of Severe Major Depression, Bipolar Disorder, Pervasive Developmental Disorder, or Psychotic Disorder.

  2. Significant medical condition such as heart disease, hypertension, liver or renal failure, pulmonary disease, seizure disorder that may require more pressing treatment.

  3. Initiation or discontinuation of a psychotropic medication treatment within six weeks of enrollment in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yale University School of Medicine, Child Study Center New Haven Connecticut United States 06520

Sponsors and Collaborators

  • Yale University
  • National Institute of Mental Health (NIMH)
  • Tourette Association of America

Investigators

  • Principal Investigator: Denis G Sukhodolsky, Ph.D., Yale University
  • Principal Investigator: Lawrence D Scahill, Ph.D., Yale University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00486551
Other Study ID Numbers:
  • 0102012121
  • 1R03MH067845
First Posted:
Jun 14, 2007
Last Update Posted:
Feb 11, 2022
Last Verified:
Jan 1, 2022

Study Results

No Results Posted as of Feb 11, 2022